Bloomberg Law
Bankruptcy Law
LinkedIn

WeightWatchers Jumps on Simplified Zepbound Access

April 29, 2025, 1:19 PM UTC
Allegra Fradkin
Allegra Fradkin

WeightWatchers shares were up over 40% after the company partnered with Eli Lilly to streamline members’ access to weight loss drug Zepbound.

  • Offering on-label vial prescriptions to self-pay patients through Lilly pharmacy provider Gifthealth, trackable through the WeightWatchers app

To view the source of this information, click here

To contact the reporter on this story:
Allegra Fradkin in New York at afradkin@bloomberg.net

To contact the editor responsible for this story:
Zachary Fleming at zfleming2@bloomberg.net

© 2025 Bloomberg L.P. All rights reserved. Used with permission.

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.